PRETI, Lorenzo
PRETI, Lorenzo
Dipartimento di Scienze dell’Ambiente e della Prevenzione
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy
2022 Marchesi, E.; Cortesi, R.; Preti, L.; Rimessi, P.; Sguizzato, M.; Bovolenta, M.; Perrone, D.
Design, synthesis, and purification of biopharmaceuticals, included highly modified oligonucleotides.
2024 Preti, Lorenzo
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
2023 Marchesi, E.; Gentili, V.; Bortolotti, D.; Preti, L.; Marchetti, P.; Cristofori, V.; Fantinati, A.; Rizzo, R.; Trapella, C.; Perrone, D.; Navacchia, M. L.
Enhancement of the Biological and Mechanical Performances of Sintered Hydroxyapatite by Multiple Ions Doping
2020 Sprio, S.; Dapporto, M.; Preti, L.; Mazzoni, E.; Iaquinta, M. R.; Martini, F.; Tognon, M.; Pugno, N. M.; Restivo, E.; Visai, L.; Tampieri, A.
Enzymatic Synthesis of New Acetoacetate–Ursodeoxycholic Acid Hybrids as Potential Therapeutic Agents and Useful Synthetic Scaffolds as Well
2024 Venturi, Valentina; Marchesi, Elena; Perrone, Daniela; Costa, Valentina; Catani, Martina; Aprile, Simona; Lerin, Lindomar Alberto; Zappaterra, Federico; Giovannini, Pier Paolo; Preti, Lorenzo
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids
file con accesso da definire2024 Marchesi, Elena; Melloni, Elisabetta; Casciano, Fabio; Pozza, Elena; Argazzi, Roberto; De Risi, Carmela; Preti, Lorenzo; Perrone, Daniela; Navacchia, Maria Luisa
Expanding the Toolbox of Heterogeneous Asymmetric Organocatalysts: Bifunctional Cyclopropenimine Superbases for Enantioselective Catalysis in Batch and Continuous Flow
2021 Leonardi, Costanza; Brandolese, Arianna; Preti, Lorenzo; Bortolini, Olga; Polo, Eleonora; Dambruoso, Paolo; Ragno, Daniele; DI CARMINE, Graziano; Massi, Alessandro
Expanding the Toolbox of Heterogeneous Asymmetric Organocatalysts: Bifunctional Cyclopropenimine Superbases for Enantioselective Catalysis in Batch and Continuous-Flow
file con accesso da definire2021 Leonardi, Costanza; Brandolese, Arianna; Preti, Lorenzo; Poletti, Lorenzo; Bortolini, Olga; Polo, Eleonora; Dambruoso, Paolo; Ragno, Daniele; DI CARMINE, Graziano; Massi, Alessandro
Modified nucleosides, nucleotides and nucleic acids via click azide-alkyne cycloaddition for pharmacological applications
2021 Perrone, D.; Marchesi, E.; Preti, L.; Navacchia, M. L.
N-Heterocyclic Carbene (NHC)-Organocatalyzed kinetic resolution of biologically active Biginelli compounds
2019 Brandolese, A.; Ragno, D.; Di Carmine, G.; Preti, L.; Buoso, S.; Botti, G.; Bortolini, O.; Massi, A.
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids
2022 Melloni, E.; Marchesi, E.; Preti, L.; Casciano, F.; Rimondi, E.; Romani, A.; Secchiero, P.; Navacchia, M. L.; Perrone, D.
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach
2021 Marchesi, E.; Bovolenta, M.; Preti, L.; Capobianco, M. L.; Mamchaoui, K.; Bertoldo, M.; Perrone, D.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy | 2022 | Marchesi, E.; Cortesi, R.; Preti, L.; Rimessi, P.; Sguizzato, M.; Bovolenta, M.; Perrone, D. | |
Design, synthesis, and purification of biopharmaceuticals, included highly modified oligonucleotides. | 2024 | Preti, Lorenzo | |
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2 | 2023 | Marchesi, E.; Gentili, V.; Bortolotti, D.; Preti, L.; Marchetti, P.; Cristofori, V.; Fantinati, A....; Rizzo, R.; Trapella, C.; Perrone, D.; Navacchia, M. L. | |
Enhancement of the Biological and Mechanical Performances of Sintered Hydroxyapatite by Multiple Ions Doping | 2020 | Sprio, S.; Dapporto, M.; Preti, L.; Mazzoni, E.; Iaquinta, M. R.; Martini, F.; Tognon, M.; Pugno,... N. M.; Restivo, E.; Visai, L.; Tampieri, A. | |
Enzymatic Synthesis of New Acetoacetate–Ursodeoxycholic Acid Hybrids as Potential Therapeutic Agents and Useful Synthetic Scaffolds as Well | 2024 | Venturi, Valentina; Marchesi, Elena; Perrone, Daniela; Costa, Valentina; Catani, Martina; Aprile,... Simona; Lerin, Lindomar Alberto; Zappaterra, Federico; Giovannini, Pier Paolo; Preti, Lorenzo | |
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids | 2024 | Marchesi, Elena; Melloni, Elisabetta; Casciano, Fabio; Pozza, Elena; Argazzi, Roberto; De Risi, C...armela; Preti, Lorenzo; Perrone, Daniela; Navacchia, Maria Luisa | file con accesso da definire |
Expanding the Toolbox of Heterogeneous Asymmetric Organocatalysts: Bifunctional Cyclopropenimine Superbases for Enantioselective Catalysis in Batch and Continuous Flow | 2021 | Leonardi, Costanza; Brandolese, Arianna; Preti, Lorenzo; Bortolini, Olga; Polo, Eleonora; Dambruo...so, Paolo; Ragno, Daniele; DI CARMINE, Graziano; Massi, Alessandro | |
Expanding the Toolbox of Heterogeneous Asymmetric Organocatalysts: Bifunctional Cyclopropenimine Superbases for Enantioselective Catalysis in Batch and Continuous-Flow | 2021 | Leonardi, Costanza; Brandolese, Arianna; Preti, Lorenzo; Poletti, Lorenzo; Bortolini, Olga; Polo,... Eleonora; Dambruoso, Paolo; Ragno, Daniele; DI CARMINE, Graziano; Massi, Alessandro | file con accesso da definire |
Modified nucleosides, nucleotides and nucleic acids via click azide-alkyne cycloaddition for pharmacological applications | 2021 | Perrone, D.; Marchesi, E.; Preti, L.; Navacchia, M. L. | |
N-Heterocyclic Carbene (NHC)-Organocatalyzed kinetic resolution of biologically active Biginelli compounds | 2019 | Brandolese, A.; Ragno, D.; Di Carmine, G.; Preti, L.; Buoso, S.; Botti, G.; Bortolini, O.; Massi, A. | |
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids | 2022 | Melloni, E.; Marchesi, E.; Preti, L.; Casciano, F.; Rimondi, E.; Romani, A.; Secchiero, P.; Navac...chia, M. L.; Perrone, D. | |
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach | 2021 | Marchesi, E.; Bovolenta, M.; Preti, L.; Capobianco, M. L.; Mamchaoui, K.; Bertoldo, M.; Perrone, D. |